Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy

AP Zavascki, CG Carvalhaes, RC Picao… - Expert review of anti …, 2010 - Taylor & Francis
Pseudomonas aeruginosa and Acinetobacter baumannii are major nosocomial pathogens
worldwide. Both are intrinsically resistant to many drugs and are able to become resistant to …

The use of noncarbapenem β-lactams for the treatment of extended-spectrum β-lactamase infections

PD Tamma, J Rodriguez-Baňo - Clinical Infectious Diseases, 2017 - academic.oup.com
The continued rise in infections caused by extended-spectrum β-lactamase (ESBL)–
producing pathogens is recognized globally as one of the most pressing concerns facing the …

Ceftolozane/tazobactam: place in therapy

DR Giacobbe, M Bassetti, FG De Rosa… - Expert review of anti …, 2018 - Taylor & Francis
ABSTRACT Introduction: Ceftolozane/tazobactam (C/T) is a new antibiotic resulting from the
combination of a novel cephalosporin, structurally similar to ceftazidime, with tazobactam, a …

[HTML][HTML] Augmented renal clearance and how to augment antibiotic dosing

IH Chen, DP Nicolau - Antibiotics, 2020 - mdpi.com
Augmented renal clearance (ARC) refers to the state of heightened renal filtration commonly
observed in the critically ill. Its prevalence in this patient population is a consequence of the …

[HTML][HTML] Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock–does the dose matter?

F Pea, P Viale - Critical Care, 2009 - Springer
Appropriate antibiotic therapy in patients with severe sepsis and septic shock should mean
prompt achievement and maintenance of optimal exposure at the infection site with broad …

Antimicrobial stewardship: concepts and strategies in the 21st century

RC Owens Jr - Diagnostic microbiology and infectious disease, 2008 - Elsevier
Large worldwide surveillance studies report that resistance to nearly all classes of
antimicrobial is increasing, as is the emergence of what have been termed pan-drug …

Piperacillin/tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations from the United States Committee on Antimicrobial …

TP Lodise, SM Bhavnani, PG Ambrose… - Clinical Infectious …, 2024 - academic.oup.com
The in vitro susceptibility testing interpretive criteria (STIC) for TZP against Enterobacterales
were recently updated by the Food and Drug Administration (FDA), Clinical & Laboratory …

[HTML][HTML] Management of infections pre-and post-liver transplantation: report of an AISF consensus conference

S Fagiuoli, A Colli, R Bruno, A Craxì, GB Gaeta… - Journal of …, 2014 - Elsevier
The burden of infectious diseases both before and after liver transplantation is clearly
attributable to the dysfunction of defensive mechanisms of the host, both as a result of …

Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion

L Lorente, A Jiménez, MM Martín, JL Iribarren… - International journal of …, 2009 - Elsevier
The standard mode of administration of piperacillin treatment is by intermittent infusion.
However, continuous infusion may be advantageous as β-lactam antibiotics exhibit time …

Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia

AM Nicasio, RE Ariano, SA Zelenitsky… - Antimicrobial agents …, 2009 - Am Soc Microbiol
ABSTRACT A population pharmacokinetic model of cefepime was constructed from data
from adult critical care patients with ventilator-associated pneumonia (VAP). A total of 32 …